Last edition
News about "Cipla"
Alembic Pharma Names Ramesh Juneja as EVP, Human Health
Alembic Pharmaceuticals has appointed Ramesh Juneja as Executive Vice President–Human Health for its India business. Bringing leadership experience from Sun Pharma, Cipla and Reliance Retail, Juneja will spearhead sales and marketing initiatives to drive growth in Alembic’s domestic pharmaceutical business.
Cipla | 02/06/2026 | By News Bureau | 100
Pfizer Reaches Three Settlement Deals for VYNDAMAX
Pfizer reaches three settlement agreements for VYNDAMAX, extending US patent exclusivity to June 1, 2031, subject to the outcome of other litigation.
Cipla | 30/04/2026 | By News Bureau | 211
Cipla Launches Saxenda for Weight Management
Cipla has strengthened its US portfolio with the launch of a generic version of Saxenda (liraglutide injection), indicated for chronic weight management. The launch follows ANDA approval from the US Food and Drug Administration (FDA), granted to its partner Orbicular, paving the way for expanded access to a more affordable GLP-1 therapy in the US.
Cipla | 02/03/2026 | By News Bureau | 189
Pfizer and Cipla Form Exclusive Marketing Partnership for Select Brands in India
Pfizer and Cipla have joined forces in an exclusive marketing and distribution agreement for select brands in India. The collaboration aims to improve access and availability of these key medicines, ensuring patients across the country benefit from a wider reach and streamlined supply.
Cipla | 19/12/2025 | By News Bureau | 235
Cipla Partners with Stempeutics, Launches Stem Cell Therapy for Knee Osteoarthritis
Cipla has partnered with Stempeutics to launch Ciplostem, a single-dose stem cell therapy for knee osteoarthritis. The treatment uses 25 million expanded Bone Marrow–derived Mesenchymal Stem Cells (BM-MSCs) combined with hyaluronic acid to support joint repair and pain relief.
Cipla | 04/12/2025 | By Dineshwori | 215
Cipla Launches India's First Dedicated Lung Health Diagnostics Centre in Delhi
Cipla has opened the country’s first dedicated lung diagnostics centre in Delhi, equipped to conduct over 60 tests across respiratory function, microbial studies, immune profiling, blood chemistry and imaging.
Cipla | 29/11/2025 | By Dineshwori | 202
Cipla to Acquire Inzpera Healthsciences for INR 110 Crore
Cipla Limited has announced that it will acquire a 100 percent stake in Inzpera Healthsciences Limited for a total consideration of approximately INR 110 crore.
Cipla | 05/11/2025 | By Darshana | 381
Cipla Elevates Achin Gupta as Next Managing Director and Global CEO
Cipla has announced the elevation of Achin Gupta as its next Managing Director and Global Chief Executive Officer, effective April 1, 2026. Currently serving as the company’s Global Chief Operating Officer, Gupta will take over from Umang Vohra, who will step down upon completion of his term on March 31, 2026.
Cipla | 30/10/2025 | By Dineshwori | 420
Kemwell Biopharma’s drug-product manufacturing facility in Bengaluru has received clearance from the US Food and Drug Administration (FDA) for the commercial manufacturing and testing of injectable products intended for the US market, following the successful completion of a pre-approval inspection (PAI).
Cipla | 29/10/2025 | By Dineshwori | 443
Eli Lilly And Cipla Partner to Distribute Yurpeak (Tirzepatide) in India
Eli Lilly and Cipla have signed an agreement to distribute and promote tirzepatide in India under a second brand name, Yurpeak.
Cipla | 27/10/2025 | By Dineshwori | 602
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy